Search Criteria
Products meeting the search criteria
Brand: Square Pharmaceuticals
Product ID: Salbutamol
Salbutamol 100mcg/puff or actuation; metered dose inhalation (MDI). 200 dose unit: 250.00 MRPIndication:Salbutamol HFA Inhaler is indicated for the treatment or prevention of bronchospasm in adults and children 4 years of age and older with reversible obstructive airway disease and for the preventio..
Tk250.00
Brand: Square Pharmaceuticals
Product ID: Salbutamol
Salbutamol sulph. 2mg/5ml: syrup 100ml bot: 23.00 MRPIndication:For use in Asthma, Chronic Bronchitis, Emphysema and other conditions associated with airways obstruction.Dosage & Administration:Syrup: Children-• 2-6 years: 2.5 ml syrup, 3-4 times daily• 6-12 years: 5 ml syrup, 3-4 times daily• Over ..
Tk23.00
Brand: Square Pharmaceuticals
Product ID: Salbutamol Sulphate
Indication:Treatment of severe acute asthma (status asthmaticus) and also forms of bronchospasm in adults & children. It is also effective in children >18 months.Dosage & Administration:By Intermittent Administration : Adult : Sultolin® Respirator Solution 0.5-1.0 ml should be diluted to final ..
Tk120.82
Brand: Square Pharmaceuticals
Product ID: Salbutamol
Sultolin HFA RefillIndication:Bronchial asthma, Chronic bronchitis, Emphysema.Dosage & Administration:Sultolin® tablet: 2-4 mg tablet 3-4 times daily. Sultolin® SR tablet: 8 mg tablet twice daily, Sultolin® syrup: 1-2 mg 3 to 4 times daily. Not recommended below 2 years of age. Sultol..
Tk250.00
Brand: Square Pharmaceuticals
Product ID: Salbutamol
Sultolin SR TabIndication:For use in Asthma, Chronic Bronchitis, Emphysema and other conditions associated with airways obstruction.Dosage & Administration:Syrup: Children-• 2-6 years: 2.5 ml syrup, 3-4 times daily• 6-12 years: 5 ml syrup, 3-4 times daily• Over 12 years: 5-10 ml syrup, 3-4 times dai..
Tk0.92
Brand: Square Pharmaceuticals
Product ID: Salbutamol
Indication:Sultolin® Cozycap is indicated both for treatment and prophylaxis of bronchospasm in bronchial and exercise-induced asthma in patients 4 years of age and older, and also for treatment of other conditions, such as bronchitis and emphysema associated with reversibleairways obstruction...
Tk2.51
Showing 1 to 6 of 6 (1 Pages)





